Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Chemotherapy Regimens for Advanced AIDS-KS
NCT01435018Phase 3Completed
- Start
- Oct 2013
- Primary completion
- Mar 2018
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of etoposide, bleomycin and vincristine sulfate liposome injection in Kaposi sarcoma (KS) (3 arms). Primary endpoint: Progression-Free Survival at 48 weeks. Started Oct 2013; status: completed.
02
Drugs
etoposidebleomycinvincristine sulfate liposome injection
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT01435018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435018.